Sascan Meditech Private Limited specializes in the early detection of potentially malignant lesions using advanced multispectral imaging technology. The company operates in the healthcare diagnostics market, focusing on innovative solutions for cancer detection. Its flagship product, OralScan, is an optical imaging multimodal device designed to identify pre-cancerous lesions in the oral cavity. The device leverages diffuse reflectance and tissue autofluorescence to detect biochemical and morphological changes in tissues, which are indicative of early-stage cancer. Sascan primarily serves healthcare providers, including hospitals, clinics, and dental practices, offering them a reliable tool for early cancer screening. The business model revolves around the sale and distribution of its diagnostic devices, supplemented by training and support services for medical professionals. Revenue is generated through direct sales, partnerships, and potentially through licensing agreements. Sascan has garnered recognition for its innovative approach, winning awards such as the Pharma and Medical Devices Startup India Grand Challenge 2021 and the National Startup India Award 2021 in the Diagnostics category.

Keywords: multispectral imaging, early cancer detection, oral cancer, healthcare diagnostics, optical imaging, pre-cancerous lesions, diffuse reflectance, tissue autofluorescence, medical devices, cancer screening.